Congleton Jon
Insider CIK 1644975 · IMUX Director · AVLN Director · NVLS President and CEO, Director · MLYS Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | S Sale | 2026-09-30 | 2026-10-02 | 75,000 | $25.46 | $1.91M | 528,621 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-07-13 | 2026-07-15 | 10,700 | $27.24 | $291.5K | 603,621 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-07-05 | 2026-07-07 | 25,370 | — | $0 | 25,370 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-30 | 2026-06-30 | 58,000 | $25.94 | $1.50M | 631,321 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-06-30 | 2026-06-30 | 17,000 | $26.82 | $455.9K | 614,321 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-06-29 | 2026-06-29 | 50,740 | — | $0 | 50,740 | SEC↗ |
| AVLN Avalyn Pharma Inc. | A Award deriv | 2026-04-29 | 2026-05-01 | 26,978 | — | $0 | 26,978 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-04-13 | 2026-04-15 | 15,730 | $26.83 | $422.0K | 689,321 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-31 | 2026-04-02 | 55,183 | $26.54 | $1.46M | 705,504 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-31 | 2026-04-02 | 453 | $27.05 | $12.3K | 705,051 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-03-31 | 2026-04-02 | 19,364 | $25.50 | $493.8K | 760,687 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 187,900 | — | $0 | 187,900 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 140,900 | — | $0 | 780,051 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-12 | 2026-01-13 | 7,117 | $33.15 | $235.9K | 639,151 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2026-01-12 | 2026-01-13 | 9,119 | $32.21 | $293.7K | 646,268 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise deriv | 2025-11-21 | 2025-11-24 | 24,082 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | M Exercise | 2025-11-21 | 2025-11-24 | 24,082 | $0.54 | $13.0K | 655,387 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 12,806 | $41.64 | $533.2K | 818,499 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 8,862 | $42.31 | $375.0K | 809,637 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 4,000 | $43.50 | $174.0K | 805,637 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 29,207 | $45.20 | $1.32M | 776,430 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 112,275 | $45.83 | $5.15M | 664,155 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-11-11 | 2025-11-13 | 32,850 | $46.89 | $1.54M | 631,305 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-10-13 | 2025-10-15 | 13,548 | $42.63 | $577.6K | 832,857 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-10-13 | 2025-10-15 | 1,552 | $43.03 | $66.8K | 831,305 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-07-11 | 2025-07-15 | 15,884 | $14.51 | $230.5K | 846,405 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-04-11 | 2025-04-15 | 15,319 | $12.19 | $186.7K | 862,289 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 570,000 | — | $0 | 570,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2025-01-13 | 2025-01-15 | 18,333 | $9.06 | $166.1K | 877,608 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-10-11 | 2024-10-15 | 15,271 | $13.52 | $206.5K | 895,941 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-07-11 | 2024-07-12 | 15,746 | $13.34 | $210.1K | 911,212 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-20 | 2024-06-20 | 14,940 | $11.73 | $175.2K | 926,958 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-18 | 2024-06-20 | 16,607 | $11.99 | $199.1K | 941,898 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-17 | 2024-06-20 | 17,766 | $12.25 | $217.6K | 958,505 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-14 | 2024-06-14 | 16,229 | $12.52 | $203.2K | 976,271 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-13 | 2024-06-14 | 39,961 | $12.74 | $509.1K | 992,500 | SEC↗ |
| MLYS Mineralys Therapeutics, In | S Sale | 2024-06-12 | 2024-06-14 | 16,607 | $12.77 | $212.1K | 1,032,461 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-02-13 | 2024-02-15 | 425,000 | — | $0 | 425,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-11-22 | 2023-11-27 | 4,250 | $5.97 | $25.4K | 1,049,068 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-09-06 | 2023-09-08 | 2,250 | $12.08 | $27.2K | 1,044,818 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-08-17 | 2023-08-21 | 2,250 | $12.10 | $27.2K | 1,042,568 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-08-11 | 2023-08-11 | 2,000 | $12.89 | $25.8K | 1,040,318 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-03-17 | 2023-03-21 | 99,800 | — | $0 | 99,800 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 250,046 | — | $0 | 250,046 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2016-09-12 | 2016-09-14 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2016-06-16 | 2016-06-17 | 5,000 | $3.87 | $19.4K | 20,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2016-03-24 | 2016-03-25 | 5,000 | $4.22 | $21.1K | 15,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2016-03-22 | 2016-03-23 | 5,000 | $4.38 | $21.9K | 10,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2015-12-11 | 2015-12-14 | 5,000 | $8.10 | $40.5K | 5,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2015-09-11 | 2015-09-15 | 121,100 | — | $0 | 121,100 | SEC↗ |